SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-251575
Filing Date
2021-08-19
Accepted
2021-08-19 17:07:03
Documents
8
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A d177587dpre14a.htm PRE 14A 188266
2 GRAPHIC g177587g01w73.jpg GRAPHIC 20526
3 GRAPHIC g177587g05p11.jpg GRAPHIC 38391
4 GRAPHIC g177587g77b61.jpg GRAPHIC 22858
5 GRAPHIC g177587g86j96.jpg GRAPHIC 109472
6 GRAPHIC g177587g88x14.jpg GRAPHIC 148917
7 GRAPHIC g177587g93c88.jpg GRAPHIC 50476
8 GRAPHIC g177587g97l53.jpg GRAPHIC 25567
  Complete submission text file 0001193125-21-251575.txt   763481
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33500 | Film No.: 211190980
SIC: 2834 Pharmaceutical Preparations